Details of the Drug Formulaction

General Information of Drug Formulation (ID: F00025)

• Formulation Name: Acamprosate 333 mg tablet
• Company: Cadila Healthcare; Zydus Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Acamprosate	(DMO381I)	Alcohol dependence	6C40.2	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Magnesium stearate	(E00208)	11177	lubricant
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Sodium bicarbonate	(E00424)	516892	Alkalizing agent; Diluent
Sodium lauryl sulfate	(E00464)	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant